Lixiana 15 mg
Lixiana 15 mg is a medicine authorised by Swissmedic under authorisation number 65149. The authorisation holder is Daiichi Sankyo (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 31 March 2015 and the authorisation is valid without a time limit. ATC code B01AF03 places the medicine in the group Antithrombotic agents.
| Authorisation number | 65149 |
|---|---|
| Name | Lixiana 15 mg |
| Full name | Lixiana 15 mg, Filmtabletten |
| Authorisation holder | Daiichi Sankyo (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AF03 |
| First authorisation | 31 March 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lixiana 15 mg, Filmtabletten | B | 31 March 2015 |
| 2 | Lixiana 30 mg, Filmtabletten | B | 31 March 2015 |
| 3 | Lixiana 60 mg, Filmtabletten | B | 31 March 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Tablette(n) | B01AF03 | 06.03.0. | B |
| 3 | 28 | Tablette(n) | B01AF03 | 06.03.0. | B |
| 4 | 98 | Tablette(n) | B01AF03 | 06.03.0. | B |
| 8 | 28 | Tablette(n) | B01AF03 | 06.03.0. | B |
| 9 | 98 | Tablette(n) | B01AF03 | 06.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Lixiana 15 mg authorised in Switzerland?
Yes. Lixiana 15 mg is authorised by Swissmedic under authorisation number 65149, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Lixiana 15 mg have?
Lixiana 15 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Lixiana 15 mg?
The authorisation holder is Daiichi Sankyo (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.